Safety, Reactogenicity, & Immunogenicity of Cytomegalovirus Vaccines

See also
Status	Clinical Trial	Phase
Completed	`NCT00023036` - Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Terminated	`NCT01037712` - In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir	Phase 4
Completed	`NCT00370006` - Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM	Phase 1
Completed	`NCT01588015` - Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant	Phase 1
Completed	`NCT01552369` - CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")	Phase 4
Completed	`NCT00223925` - Maribavir for Prevention of CMV After Stem Cell Transplants	Phase 2
Active, not recruiting	`NCT05085366` - A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age	Phase 3
Completed	`NCT01220895` - Alternate Donor Study of Pre-Emptive Cellular Therapy	Phase 2
Completed	`NCT00942305` - Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients	Phase 2
Completed	`NCT00373412` - Trial of pDNA CMV Vaccine (VCL-CT02) Followed by Towne CMV Vaccine (Towne) Challenge	Phase 1
Completed	`NCT05105048` - A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647	Phase 1
Completed	`NCT00386412` - TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant	Phase 2
Completed	`NCT02454699` - Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers	Phase 1
Active, not recruiting	`NCT03910478` - Dried Blood Spot Testing of CMV Detection in HCT Recipients	N/A
Completed	`NCT01354301` - Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate	Phase 4
Active, not recruiting	`NCT01473849` - Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients	N/A
Completed	`NCT00880789` - Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus	Phase 1
Completed	`NCT00817908` - Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients	N/A
Completed	`NCT00273143` - A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.	Phase 1
Completed	`NCT00194155` - Cytomegalovirus (CMV) Infection in Pregnancy	N/A

NCT number	NCT03382405
Study type	Interventional
Source	ModernaTX, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	November 13, 2017
Completion date	October 28, 2020

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms